A patient with hyperglycaemia and normal HbAIC due to impaired glycation

Netherlands Journal of Medicine

Volumn 65, Issue 10, 2007, Pages 395-397

  Diekman, M J M ^a   Salden, H J M ^a   DeVries, J H ^b  

^a DEVENTER HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glycation; Hb Philadelphia; HbAIC; Hemoglobinopathy

Indexed keywords

ACETYLSALICYLIC ACID; FRUCTOSAMINE; GLIBENCLAMIDE; GLUTAMINE; HEMOGLOBIN A; HEMOGLOBIN A1C; LYSINE; METFORMIN; VERAPAMIL;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CAUCASIAN; DIABETES MELLITUS; DIABETIC PATIENT; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA;

AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FRUCTOSAMINE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MASS SPECTROMETRY;

EID: 36448962757     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rahbar S, Blumenfeld D, Ranney HM,. Studies of an unusual haemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969;36:838-43.
2. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353-7.
3. The Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med 1993;329:977.
4. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
5. Shapiro R, McManus MJ, Zalut C, Bunn HF. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem 1980;255:3120.
6. Roberts NB, Amara AB, Morris M, Green BN. Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated haemoglobin. Clin Chem 2001;47:316-21.
7. Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 1999;36:451-9.
8. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313-20.
9. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-7.
10. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-5.
11. Rahbar S, Natarajan R, Yerneni K, Scott S, Gonzales N, Nadler JL. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Clin Chim Acta 2000;301:65-77..
12. Rendell M, Nierenberg J, Brannan C, et al. Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo. J Lab Clin Med 1986;108:286-93.
13. Peterson KP, Pavlovich JG, Goldstein D, Little R, England J, Peterson CM. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem. 1998;44:1951-8.
14. 2 5 (A2) Pro→Ala], an electrophoretically silent variant with impaired glycation. Clin Chem 2003;49:137-43.